Exam 2 Flashcards
INH MOA
Bactericidal
May inhibit mycolic acid synthesis and disrupt cell wall
Rifampin MOA
Bactericidal
Inhibits bacterial DNA- dependent RNA polymerase RNA synthesis by blocking the initiation of RNA transcription
Rifabutin MOA
Bactericidal. Inhibits DNA dependent RNA polymerase
Ethambutanol MOA
Bacteriostatic
Appears to suppress multiplication by interfering with RNA synthesis, effective only against actively dividing.
Pyrazinamide MOA
Unknown
Static or cidal depending on concentration and susceptibility of organism
Streptomycin MOA
Bactericidal
Interferes with initiation complex between mRNA and 30S ribosomal subunit causing DNA to be misread and thus nonfunctional proteins are produced leading to cell death
PD of antimycobacterials
Streptomycin- concentration dependent killing
The rest- time-dependent killing
Streptomycin and rifampin have prolonged PAE thus protecting against re-growth when levels fall below MIC
Spectrum of activity for antimycomacterials
Resistance may occur if any of these drugs are used alone for active treatment
All have activity for Mycobacterium tuberculosis
Some have activity for non-tuberculosis mycobacteria
Rifampin spectrum of activity
M. tuberculosis, M. leprae, H. influenzae, S. aureus, S. epidermidis, staphylococci, most streptococci, some Enterobacterales
Antimycobacterials renal dosing
Renal dose adjustments for pyrazinamide, ethambutol, levofloxacin, aminoglycosides if CrCl <30mL/min
Antimycobacterials hepatotoxicity
Isoniazid, rifampin, pyrazinamide
Pyrazinamide most likely to cause hepatotoxicity
Peripheral neuropathy of antimycobacterials
INH, PZA, and quinolones
Pregnant women, alcoholics, and patients with poor diets shuold recieve pyridozine daily
INH drug interaction
alcohol
rifampin and other hepatotoxic drugs
Ketoconazole
Rifampin drug interactions
alcohol INH and hepatotoxic drugs Aminophylline and theophylline Coumadin Oral diabetic agents Azoles Chloramphenicol Oral contraceptives Corticosteroids Digoxin Propafenone Quinidine Estrogen PHT Verapamil ALL increased metabolism by rifampin
Ethambutol DDI
antacids my delay and reduce abs
Pyrazinamide DDI
cyclosporine
Streptomycin DDI
aminoglycosides, capreomyxin, polymyxins
Antimycobacterials patient monitoring
LFTs and monitor for symptoms of liver disease CBC Visual exam Hearing exam and renal function Serum conc. monitoring with streptomycin
Prophylaxis of TB drugs
INH + Rifapentine
Tx of TB drugs
INH, rifampin, ethambutol, pyrazinamide, streptomycin
Mycobacterium tuberculosis
Acid fast bacteria Slow-growing Difficult to culture (2-3 weeks for susceptibilities) Most prevalent and deadly ID globally Drug resistance is major concern
How is TB spread?
aerolized droplet nuceli
TB airborne precautions
Negative-pressure room
Personal protective equipment, N95 respirator
May be D/Cd after 3 consecutive days of negative AFB sputum smears
TB presentation
Weight loss, fatigue, productive cough often with hemoptysis
Sputum smear with acid-fast bacilli (AFB)
Upper lobes of lung with patchy or nodular infiltrates
Positive skin test
Extrapulmonary TB
Lymphatic and pleural space most common sites
More common in patients with HIV
Typically treated with conventional TB regimens
TB meningitis- 9-12 months therapy
Directly observed therapy (DOT)
the standard of care for tx of active Tb
Long duration of therapy after improvement of symptoms
Tx of active tb
Initial phase (months 1-2)- isoniazid, rifampin, pyrazinamide, ethambutol Continuation phase (months 3-6)- isoniazid, rifampin. Extended to 7 months if positive cultures show after 2 months
Ethambutol can be D/Cd once susceptibility to other agents is shown.
5 days/week DOT therapy most effective
Tx of latent TB (LTBI)
Once weekly INH + Rifapentine for 12 weeks
Bulbar neuritis
Ethambutol
Monitor for vision changes and loss of red-green differentiation
Resistance in TB
Resistance to first-line therapy is common
Multidrug resistant TB- use Bedaquiline- based regimen
If resistance is discovered add at least 2 drugs to which the organism is susceptible
Antifungal therapy cell membrane
Nystatin
Amphotericin B
Azole antifungals
Antifungal therapy DNA/RNA synthesis target
5-Flucytosine
Antifungal therapy cell wall target
Echinocandins
Nystatin MOA
Binds to sterols in the fungus cell membrane, affecting cell wall permeability and allowing for leakage of intracellular contents out of the cell leading to cell death.
Nystatin spectrum
Candida Spp
Nystatin clinical use
Oral candidiasis, decontamination prior to surgery
Amphotericin B MOA
Binds to ergosterol on fungal cell membranes causing destabilization which affects cell wall permeability and allows for vital substances to leak out of the cell, leading to death
Amphotericin B spectrum
Candida Spp. (C. lustaniae resistant) Histoplasma crytptococcus aspergillus blastomycosis
Amphotericin B clinical use
Crytococcal meningitis, mucormycosis, invasive fungal infections not responsive to other therapies.
Amphotericin B PK considerations
Comes in lipid based formulations and rapidly distributes into tissues
Amphotericin B DDI
Nephrotoxic drugs, azole antifungals
Amphotericin B acute toxicities
fevers, chills, hypotension, arrythmias, thrombophplebitis, HA
Amphotericin B premedicate
Need to premedicate with APAP, meperidine, and diphenhydramine 30 minutes before infusion to prevent acute toxicities.
Use meperidine only if a reaction was previously reported
Amphotericin B chronic toxicities
Nephrotoxicity, electrolyte depletion, anemia, LFT elevation
Pre and post hydrate to prevent nephrotoxicity
Ketoconazole
Spectrum- candida spp. Uses- limited PK considerations- potent CYP3A4 inhibitor AE- hepatic impairment BBW DDI- drugs that increase gastric pH
Ketoconazole BBW
Hepatic impairment
Intraconazole
Spectrum- Candida Spp., histoplasmosis, aspergillus
Uses- DOC for endemic fungi (histoplasmosis, blastomycosis, coccoidomycosis)
PK- monitor plasma conc.
AE- taste disturbance, GI
Fluconazole
Spectrum- Candida Spp.
Uses- candida infections
PK -renal dose
AE- dose-related alopecia, bone marrow suppression, Additive QTc prolongation
Voriconazole
Spectrum- Candida Spp., Aspergillus spp.
PK- cannot dialyze
AE- Dose related visual disturbances
Posaconazole
Spectrum- Candida Spp., Aspergillus Spp.
AE- Elevated LFTs, GI, intolerance, hypokalemia
Isavuconazole
Spectrum- Candida spp., aspergillus, mucormycosis
Uses- invasive aspergillus and mucormycosis
AE- N/V/D, infusion reactions
5-Flucytosine (5-fc)
Spectrum- Candida spp., crytococcus, aspergillus
Uses- cryptococcal meningitis in combo with amphotericin B
AE- Renal toxicity, dose-dependent myelosuppression, increased AST/ALT
Never use as monotherapy!
Echinocandins
Spectrum- Candida Spp.
Uses- Infections of candida Spp. resistant to azoles
PK- not dialyzable, minimal CNS
AE- fever, rash, increased LFTs
Hookworms S/Sx
Abdominal pain, iron deficiency anemia, malnutrition, loss of appetite, desire to eat soil
Hookworms tx
Mebendazole 100mg BID for 3 days or 500mg once
Albendazole 400mg once
Roundworms Tx
Mebendazole 100mg BID for 3 days ot 500mg once
Albendazole 400mg once
Pinworms Dx
Scotch tape test to look for eggs
Pinworms tx
Pyrantel pamoate 11mg/kg/day (max 1 g) for 3 days; repeat in 10-14 days
Mebendazole 100mg once; repeat in 10-14 days
Albendazole- 400mg once; repeat in 10-14 days
Tapeworms Tx
Praziquantel 5-10mg/kg once
Liver flukes where?
Ingestion (drinking water, swimming, eating infected aquatic vegetation, eating infected raw meat)
Most common in Asia, Africa, S. America, or middle east but can be found anywhere where human waste is used as a fertilizer
Liver flukes S/Sx
Chronic diarrhea, abdominal pain, ulcers, hemorrhage, abscess, liver damage